High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4 +, FHIT, E-cadherin, Ki-67, and p16 INK4a

Journal of Lower Genital Tract Disease

Volumn 15, Issue 4, 2011, Pages 280-286

  Samir, Raghad ^a   Asplund, Anna ^b   Tot, Tibor ^a   Pekar, Gyula ^a   Hellberg, Dan ^c,d  

^a FALUN HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c Center for Clinical Research   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervical epithelium; Cervical intraepithelial neoplasia; Human papillomavirus; Tumor markers

Indexed keywords

CD4 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FRAGILE HISTIDINE TRIAD PROTEIN; KI 67 ANTIGEN; UVOMORULIN;

ARTICLE; CANCER GRADING; COLPOSCOPY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; ONCOGENE C MYC; PAPANICOLAOU TEST; PROTEIN EXPRESSION; PUNCH BIOPSY; TISSUE MICROARRAY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX TUMOR; VAGINA CYTOLOGY; VERRUCA VULGARIS; WART VIRUS;

ACID ANHYDRIDE HYDROLASES; ADULT; BIOLOGICAL MARKERS; BIOPSY; CADHERINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-MYC; SEVERITY OF ILLNESS INDEX; TISSUE ARRAY ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 80053614472     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318215170c     Document Type: Article

References (26)

1. De Sanjose S, Quint WGV, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11: 1048-56.
2. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women. A longitudinal cohort study. Lancet 2001;357:1831-6. (Pubitemid 32539115)
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9. (Pubitemid 29406813)
4. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relationship between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65. (Pubitemid 34293391)
5. Ferenzy A, Franco E. Persistent human papilloma infections and cervical neoplasia. Lancet Oncol 2002;3:11-6. (Pubitemid 34121141)
6. Hellberg D, Stendahl U. The biological role of smoking, oral contraceptive use and endogenous sexual steroid hormones in invasive squamous epithelial cervical cancer (49 refs). Anticancer Res 2005;25:3041-6. (Pubitemid 41044698)
7. Kalof AN, Cooper K, Phil D. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol 2006;13:190-4. (Pubitemid 44341655)
8. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008;40:335-44. (Pubitemid 351630885)
9. Prasad CJ, Sheets E, Selig AM, McArthur MC, Crum CP. The binucleate squamous cell: histologic spectrum and relationship to low-grade squamous intraepithelial lesions. Mod Pathol 1993;6:313-7.
10. Mills SE, Carter D, Greenson JK, Reuter VE. Sternberg's Diagnostic Surgical Pathology, Vol. 2, 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009:2377-92.
11. Gustavsson I, Juko-Pecirep I, Backlund I, Wilander E, Gyllensten U. Comparison between Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia. J Clin Virol 2009;45:85-9.
12. Uhlen M, Ponten F. Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005;4:384-93. (Pubitemid 40590558)
13. FiedlerM,Muller-Holzner E, ViertlerH-P,Widschwendter A, Laich A, Pfister G, et al. High level HPV-16 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J 2004;18:1120-2. (Pubitemid 39561543)
14. Ishikawa M, Fujii T, Saito M, Nindl I, Ono A, Kubushiro K. Overexpression of p16INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 2006;16:347-53.
15. Eleuterio J, Girakdo PC, Goncalves AK, Cavalcante DIM, Ferreira FVA, Mesquita SM, et al. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus. Acta Obstet Gynecol Scand 2007;86:94-8. (Pubitemid 46009533)
16. Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopouluos G, Martin-Hirsch P, et al. p16INK4a immunostaining in cytological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treatment Rev 2009;35:210-20.
17. Branca M, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, et al. p16INK4a expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conisation or disease outcome. Int J Gynecol Pathol 2004;23:354-65. (Pubitemid 39299024)
18. Arafa M, Boniver J, Delvenne P. Detection of HPVinduced cervical (pre) neoplastic tissues. Appl Immunohistochem Mol Morphol 2008;16:422-32.
19. Braganca JF, Sarian LO, Pitta DR, Maito AB, Vassallo J, Pignataro F, et al. Expression of p16INK4a and cervical infection with high-risk human papillomavirus are not related to p53 activity in cervical intraepithelial neoplasia. Int J Gynecol Cancer 2008;18:1060-4.
20. Mimica M, Tomic S, Kardum G, Hofman ID, Kaliteran V, Pejkovic L. Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection. Int J Gynecol Cancer 2010;20:116-9.
21. Steele JC, Mann CH, Rookes S, Rollason T, Murphy D, Freeth MG, et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer 2005;93:248-59. (Pubitemid 41133212)
22. Seresini S, Origoni M, Caputo L, Lillo F, Longhi R, Vantini S, et al. Cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix. Immunology 2010;131: 89-98.
23. Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini J-S, Capilna M, Felix S, et al. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high-risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol 2006;102:22-31. (Pubitemid 44183744)
24. Bais AG, Beckmann I, Ewing PC, Eijkemans MJC, Meijer CJL, Snijders PFJ, et al. Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(j) controls. Mediators Inflamm 2007;2007:24147.
25. Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T. Increased secretion pattern of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 2004;35:1376-84. (Pubitemid 39601578)
26. Syrjanen S, Naud P, Sarian L, Derchain S, Roteli- Martins C, Longatto-Filho A, et al. Immunosuppressive cytokine interleukin-10 (IL-10) is upregulated in high-grade CINbut not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CINin the LAMS cohort. Virchows Arch 2009;455:505-15.